Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in terms of SEBI Circular No. SEBI / HO / MIRSD / MIRSD_RTAMB / P / CIR / 2022 / 8 dated January 25, 2022, Titan Biotech has informed that Registrar and Transfer Agent (RTA) on completion of the requisite formalities has issued letter of confirmation/ duplicate share certificate to the shareholder(s). The above information shall also be made available on the website of the Company.
The above information is a part of company’s filings submitted to BSE.
